Assessing Guardant Health (GH) Valuation As Shield Screening Momentum Builds With FDA Approval And Nationwide Tour [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Guardant Health (GH) just kicked off its Shield Across America mobile tour, taking its FDA approved Shield blood test for primary colorectal cancer screening directly into more than 100 communities across the country. See our latest analysis for Guardant Health. The Shield Across America tour sits against a mixed share price backdrop, with a 1 day share price return of 1.75% but a 30 day share price return decline of 18.46%. At the same time, the 1 year total shareholder return of 99.32% and 3 year total shareholder return of about 3x suggest that longer term momentum has been much stronger than recent trading. If Guardant's screening push has you thinking more broadly about healthcare opportunities, it could be a good time to scan our screener of 33 healthcare AI stocks for your next idea. With Guardant Health posting a nearly 100% 1 year total return yet trading at what some models suggest is a discount to estimated value, you have to ask: is there still a buying opportunit
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Franklin DynaTech Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- 3 Reasons to Avoid GH and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Why Guardant Health's (GH) 2026 Screening Story Reinforced Piper Sandler's Bullish View [Yahoo! Finance]Yahoo! Finance
- Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026Business Wire
GH
Earnings
- 2/19/26 - Beat
GH
Sec Filings
- 3/23/26 - Form 4
- 3/19/26 - Form 4
- 3/18/26 - Form 4
- GH's page on the SEC website